Citigroup’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Citigroup's ABMD Position: Q4 2022 in Review
Citigroup sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 40,942 shares — an estimated $10.1M sold.
Citigroup first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $14.5M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Citigroup reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Citigroup sold 40,942 Abiomed Inc shares in Q4 2022, an estimated $10.1M.
- Citigroup first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
- Citigroup's Abiomed Inc position peaked at $14.5M in Q4 2020.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.